Kavosh Mazdaroo Unveils Plant-Based Veterinary Solution to Combat Antibiotic Resistance

According to the IIID Public Relations Office, the new product addresses the global challenge of antibiotic resistance, which simultaneously threatens human, animal, and environmental health. By offering a viable alternative for treating superficial wounds, the innovation aligns with sustainable veterinary practices.

Key features and strategic impacts of the product include:

• Product Overview: "Mazohil Damy" is specifically formulated to aid in the healing of superficial wounds in livestock and poultry, serving as a complementary option alongside conventional treatments under veterinary supervision.
• Active Ingredients: The formulation utilizes tannic acid, gallic acid, and ellagic acid, which are recognized for their antibacterial, anti-inflammatory, and antioxidant properties that inhibit bacterial growth and promote tissue regeneration.
• One Health Approach: The development is rooted in the "One Health" framework, emphasizing that managing antibiotic use in veterinary medicine is critical to preventing the transmission of resistant bacteria to humans via the food chain or environment.
• Strategic Impact: By providing a plant-based alternative, the product helps mitigate the overuse of antibiotics, directly contributing to the preservation of animal health and the reduction of microbial resistance risks.

Kavosh Mazdaroo, an incubated company at the IIID, continues to focus on advanced diagnostic and therapeutic pharmaceutical products, demonstrating the district's capacity to foster solutions for critical global health challenges.

CMS Hashtags: #VeterinaryInnovation #OneHealth #AntibioticResistance #IIID #KnowledgeBasedCompanies